ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Study of Psilocybin for Anorexia in Young Adults

ClinicalTrials.gov ID: NCT06399263

Public ClinicalTrials.gov record NCT06399263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06399263
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Marissa Raymond-Flesch, MD, MPH
Other
Enrollment
40 participants

Conditions and interventions

Interventions

  • Preparation and Integration Sessions Behavioral
  • Psilocybin Drug

Behavioral · Drug

Eligibility (public fields only)

Age range
18 Years to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2024
Primary completion
Oct 31, 2029
Completion
Oct 31, 2029
Last update posted
Mar 2, 2026

2024 – 2029

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of California, San Francisco San Francisco California 94107 Not yet recruiting
University of California, San Francisco San Francisco California 94143 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06399263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06399263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →